Literature DB >> 6969214

Surface properties of LDL-binding lymphocytes in human peripheral blood.

K Hiramatsu, H Sakai, M Endoh, S Arimori.   

Abstract

Surface properties of low density lipoprotein (LDL)-binding lymphocytes were evaluated to determine whether LDL binds with a subpopulation of human peripheral blood lymphocytes (PBL). B- and T-cell rich fractions were prepared from PBL using E-rosette formation or nylon reticulum columns. Binding of FITC-labelled LDL with these cell fractions was determined with a fluorescent microscope and a fluorescence-activated cell sorter (FACS II). The specificity of the binding was evaluated by a dose-dependent inhibition of LDL binding with the addition of unlabelled lipoproteins. In parallel studies, surface properties including E-rosette formation, surface immunoglobulins, and receptors for IgG-Fc, as well as human and mouse C3 were examined. LDL binding lymphocytes were enriched in the B-cell rich fraction, and depleted in the T-cell rich fraction. In addition, FITC-LDL binding lymphocytes were selectively collected by the FACS II. These LDL binding cells restored surface immunoglobulins after incubation in serum-free medium following trypsinization. The majority of lymphocytes stimulated by PHA and PWM in vitro bound with LDL. It is concluded that LDL binds with B cells in fresh human PBL, while it binds with B and T cells in mitogen-stimulated lymphocytes. It is suggested that the selective collection of LDL binding lymphocytes by the FACS II can be applied to the evaluation of cellular interaction of these cells in various immunological reactions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969214      PMCID: PMC1457810     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  8 in total

1.  Effects of low density lipoproteins on lymphocyte stimulation.

Authors:  J Hagmann; I Weiler; E Waelti
Journal:  FEBS Lett       Date:  1979-01-15       Impact factor: 4.124

2.  Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells.

Authors:  Y K Ho; R G Smith; M S Brown; J L Goldstein
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

3.  Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

6.  Altered nucleic acid synthesis patterns in lymphocytes from patients with chronic uremia.

Authors:  J C Daniels; H Sakai; E K Cobb; A R Remmers; H E Sarles; J C Fish; W C Levin; S E Ritzmann
Journal:  Am J Med Sci       Date:  1970-03       Impact factor: 2.378

7.  Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes.

Authors:  Y K Ho; S Brown; D W Bilheimer; J L Goldstein
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

8.  Binding, internalization, and hydrolysis of low density lipoprotein in long-term lymphoid cell lines from a normal subject and a patient with homozygous familial hypercholesterolemia.

Authors:  Y K Ho; M S Brown; H J Kayden; J L Goldstein
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

  8 in total
  1 in total

Review 1.  B cells interactions in lipid immune responses: implications in atherosclerotic disease.

Authors:  Laura C Echeverri Tirado; Lina M Yassin
Journal:  Lipids Health Dis       Date:  2017-02-06       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.